Differences between revisions 63 and 74 (spanning 11 versions)

OICR Cancer Stem Cell Program

Experimental Design and Statistical Analysis

Changjiang Xu, Gary Bader

OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below)
Biostatistics service

-  ⇤ ← Revision 63 as of 2015-04-02 18:55:29 → 
  Size: 2928
  Editor: ChangjiangXu
  Comment:
+   ← Revision 74 as of 2021-06-21 20:48:17 → ⇥
  Size: 3558
  Editor: ChangjiangXu
  Comment:
-Deletions are marked like this.
+Additions are marked like this.
 Line 1:
-#acl CscGroup:read,write,revert
+#acl All:read
 Line 7:
-[[ChangjiangXu |ChangJiang Xu]], [[GaryBader | Gary Bader]]

[[https://docs.google.com/spreadsheets/d/1_U02gmzt7CQ8-FxY2Dg6GPdZybKmb7FxpELeL52Q1o8/edit#gid=0  | Active Project Tracking]]

[[https://docs.google.com/document/d/12oRcXXjSrcLLYU9aWSKmN5JVSzNFwbwes5iC29-bacI/edit | New List of Projects]]
+[[ChangjiangXu |Changjiang Xu]], [[GaryBader | Gary Bader]]
-Line 15:
+Line 11:
- * OICR CSC Projects (PI's name and/or project title listed below)
+ * OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below)
-Line 19:
+Line 15:
+     * [[CancerStemCellProject/ChangjiangXu/AS04_import_proteins_Danny | AS04_import_proteins_Danny: Gene expression of the mitochondrial import proteins MPPbeta in AML and HSC]]
-Line 23:
+Line 20:
+     * [[CancerStemCellProject/ChangjiangXu/LA03 | LA03 (LA03_part3_CAF_H&N_Keira): Crosstalk between CAFs and epithelial cancer cells in the Head and Neck cancer]]
-Line 28:
+Line 26:
-   * HALT02/JAK2
     * [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]]
     * [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]]
+   * John Dick
     * HALT02/JAK2
       1. [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]]
       1. [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]]
     * [[CancerStemCellProject/ChangjiangXu/JD12_relapsedAML | JD12_relapsedAML_Liran: Clustering and pathway analysis of patients with relapsed AML]]
     * [[CancerStemCellProject/ChangjiangXu/JD13_Itgb7_Peter | JD13_Itgb7_Peter: ITGb7+ and ITGb7– hematopoietic stem cells]]
     * [[CancerStemCellProject/ChangjiangXu/JD14_Sasan_FL_BM | JD14_Sasan_FL_BM: Differential expression analysis and gene-set enrichment analysis on hematopoietic stem cells derived from bone marrow or fetal liver]]
-Line 36:
+Line 38: